These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27509179)

  • 1. Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2.
    Matthaei J; Tzvetkov MV; Strube J; Sehrt D; Sachse-Seeboth C; Hjelmborg JB; Möller S; Halekoh U; Hofmann U; Schwab M; Kerb R; Brockmöller J
    Clin Pharmacol Ther; 2016 Dec; 100(6):606-616. PubMed ID: 27509179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors.
    Rasmussen BB; Brix TH; Kyvik KO; Brøsen K
    Pharmacogenetics; 2002 Aug; 12(6):473-8. PubMed ID: 12172216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous action of the flavonoid quercetin on cytochrome P450 (CYP) 1A2, CYP2A6, N-acetyltransferase and xanthine oxidase activity in healthy volunteers.
    Chen Y; Xiao P; Ou-Yang DS; Fan L; Guo D; Wang YN; Han Y; Tu JH; Zhou G; Huang YF; Zhou HH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):828-33. PubMed ID: 19215233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.
    Butler MA; Lang NP; Young JF; Caporaso NE; Vineis P; Hayes RB; Teitel CH; Massengill JP; Lawsen MF; Kadlubar FF
    Pharmacogenetics; 1992 Jun; 2(3):116-27. PubMed ID: 1306111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
    Fuhr U; Rost KL; Engelhardt R; Sachs M; Liermann D; Belloc C; Beaune P; Janezic S; Grant D; Meyer UA; Staib AH
    Pharmacogenetics; 1996 Apr; 6(2):159-76. PubMed ID: 9156694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.
    Koonrungsesomboon N; Khatsri R; Wongchompoo P; Teekachunhatean S
    Pharmacogenomics J; 2018 Dec; 18(6):760-768. PubMed ID: 29282363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
    Nyéki A; Buclin T; Biollaz J; Decosterd LA
    Br J Clin Pharmacol; 2003 Jan; 55(1):62-7. PubMed ID: 12534641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping.
    Kashuba AD; Bertino JS; Kearns GL; Leeder JS; James AW; Gotschall R; Nafziger AN
    Clin Pharmacol Ther; 1998 May; 63(5):540-51. PubMed ID: 9630827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
    Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.
    Josse AR; Da Costa LA; Campos H; El-Sohemy A
    Am J Clin Nutr; 2012 Sep; 96(3):665-71. PubMed ID: 22854411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
    McQuilkin SH; Nierenberg DW; Bresnick E
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):139-46. PubMed ID: 7742721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
    Dik VK; Bueno-de-Mesquita HB; Van Oijen MG; Siersema PD; Uiterwaal CS; Van Gils CH; Van Duijnhoven FJ; Cauchi S; Yengo L; Froguel P; Overvad K; Bech BH; Tjønneland A; Olsen A; Boutron-Ruault MC; Racine A; Fagherazzi G; Kühn T; Campa D; Boeing H; Aleksandrova K; Trichopoulou A; Peppa E; Oikonomou E; Palli D; Grioni S; Vineis P; Tumino R; Panico S; Peeters PH; Weiderpass E; Engeset D; Braaten T; Dorronsoro M; Chirlaque MD; Sánchez MJ; Barricarte A; Zamora-Ros R; Argüelles M; Jirström K; Wallström P; Nilsson LM; Ljuslinder I; Travis RC; Khaw KT; Wareham N; Freisling H; Licaj I; Jenab M; Gunter MJ; Murphy N; Romaguera-Bosch D; Riboli E
    Int J Cancer; 2014 Jul; 135(2):401-12. PubMed ID: 24318358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics].
    Pastera J; Anzenbacher P; Fiala Z
    Acta Medica (Hradec Kralove) Suppl; 1999; 42(1):3-5. PubMed ID: 11253312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects.
    Welfare MR; Bassendine MF; Daly AK
    Br J Clin Pharmacol; 2000 Mar; 49(3):240-3. PubMed ID: 10718779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan.
    Kobayashi M; Otani T; Iwasaki M; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Sakamoto H; Yoshida T; Tsugane S
    Scand J Gastroenterol; 2009; 44(8):952-9. PubMed ID: 19452301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Tibetan medicine zuotai on the activity, protein and mRNA expression of CYP1A2 and NAT2].
    Li XY; Liu YN; Li YP; Zhu JB; Yao XC; Li YF; Yang M; Yuan M; Fan XR; Yin YM
    Yao Xue Xue Bao; 2014 Feb; 49(2):267-72. PubMed ID: 24761621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.
    Koda M; Iwasaki M; Yamano Y; Lu X; Katoh T
    Environ Health Prev Med; 2017 Oct; 22(1):72. PubMed ID: 29165164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure levels and cytochrome P450 1A2 activity, but not N-acetyltransferase, glutathione S-transferase (GST) M1 and T1, influence urinary mutagen excretion in smokers.
    Pavanello S; Simioli P; Lupi S; Gregorio P; Clonfero E
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):998-1003. PubMed ID: 12376499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities].
    Lu JF; Yi T; Cao XM; Zhuo HT; Ling SS
    Yao Xue Xue Bao; 1997 Nov; 32(11):813-8. PubMed ID: 11596199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.